Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurotransmitter Transporters Glutamate

CNQX, AMPA / kainate antagonist (ab120017)

Price and availability

358 492 ₸

Availability

Order now and get it on Thursday February 25, 2021

CNQX, AMPA / kainate antagonist (ab120017)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • AMPA / kainate antagonist
  • CAS Number: 115066-14-3
  • Purity: > 99%
  • Soluble in DMSO to 100 mM
  • Form / State: Solid
  • Source: Synthetic

You may also be interested in

Quisqualic acid (mM/ml), group I mGlu agonist (ab146666)
Product image
Anti-EAAT3 antibody - N-terminal (ab191290)
Product image
(S)-AMPA, agonist (ab120005)
Dihydrokainic acid, EAAT2 (GLT-1) inhibitor (ab120066)

Overview

  • Product name

    CNQX, AMPA / kainate antagonist
  • Description

    AMPA / kainate antagonist
  • Biological description

    Potent, competitive AMPA / kainate receptor antagonist. Also antagonist at NMDA receptor glycine site.

  • Purity

    > 99%
  • CAS Number

    115066-14-3
  • Chemical structure

    Chemical Structure

Images

  • Functional Studies - CNQX, AMPA / kainate antagonist (ab120017)
    Functional Studies - CNQX, AMPA / kainate antagonist (ab120017)
    ab96379 staining MEK1 (phospho S298) in SK-N-SH cells treated with CNQX (ab120017), by ICC/IF. Decrease in MEK1 (phospho S298) expression correlates with increased concentration of CNQX, as described in literature.
    The cells were incubated at 37°C for 24h in media containing different concentrations of ab120017 (CNQX) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab96379 (1/100 dilution) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.
  • Cellular activation - CNQX, AMPA / kainate antagonist (ab120017)
    Cellular activation - CNQX, AMPA / kainate antagonist (ab120017) Image from Ildiko P, et al. Plos One, 8(3), e57694. Fig 4a,; doi: 110.1371/journal.pone.0057694
    Left and Middle: Representative IOS amplitude map and field response curve under control condition and under application of 20 µM CNQX, respectively. The colorbar indicates the maximum change of the transmittance compared to the resting light intensity. A Right: Spatial visualization of the percentage of control changes of IOS signal caused by CNQX application.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-HIP1 antibody [EPR10814] (ab181238)

  •  
  • Product image

    Anti-RhoGDI antibody [EPR3773] (ab133248)

  •  
  • Product image

    Anti-TMEM173 antibody [EPR13130-55] (ab239074)

  •  
  • Product image

    Anti-Menin antibody - ChIP Grade (ab31902)

  •  
  • Product image

    Anti-Ras antibody [EPR18713-13] (ab206969)

  •  
  • Product image

    Anti-CD94 antibody [EPR21003] (ab235441)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.